Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
73M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
59M
-
Shares change
-
+16.4M
-
Total reported value, excl. options
-
$324M
-
Value change
-
+$115M
-
Put/Call ratio
-
1
-
Number of buys
-
73
-
Number of sells
-
-72
-
Price
-
$5.50
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q1 2024
162 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59M shares
of 73M outstanding shares and own 80.76% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (5.89M shares), BlackRock Inc. (3.75M shares), VANGUARD GROUP INC (3.71M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.54M shares), FARALLON CAPITAL MANAGEMENT LLC (3.17M shares), TANG CAPITAL MANAGEMENT LLC (3.1M shares), Cormorant Asset Management, LP (2.71M shares), Point72 Asset Management, L.P. (2.53M shares), Schonfeld Strategic Advisors LLC (2.37M shares), and Capital International Investors (2.35M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.